CXCR4 and neoplasm: These studies have also shown that CXCR4/CXCL12 interaction in the tumor microenvironment may help maintain an immune-quiescent microenvironment, and that antagonism of CXCR4 may render NSCLC cells more sensitive to chemotherapy [42,43].